IP Verse

Methods Of Cancer Treatment With Antagonists Against Pd-1 And Pd-L1 In Combination With Radiation Therapy

Patent No. EP3157629 (titled "Methods Of Cancer Treatment With Antagonists Against Pd-1 And Pd-L1 In Combination With Radiation Therapy") was filed by Medimmune on Jun 17, 2015. The application was issued on Oct 5, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TESAROJul 4, 2023DRURY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3157629

MEDIMMUNE
Application Number
EP15733375A
Filing Date
Jun 17, 2015
Status
Opposition Rejected
Mar 21, 2025
Publication Date
Oct 5, 2022
External Links
Slate, Register , Google Patents